Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).

Authors

AeRang Kim, George Washington University
Yao Lu
Scott H Okuno
Denise Reinke
Ophélia Maertens
John Perentesis
Mitali Basu
Pamela L Wolters
Thomas De Raedt
Sant Chawla
Rashmi Chugh
Brian A Van Tine
Geraldine O'Sullivan
Alice Chen
Karen Cichowski
Brigitte C Widemann

Document Type

Journal Article

Publication Date

1-30-2020

Journal

Sarcoma

Volume

2020

DOI

10.1155/2020/5784876

Comments

eCollection 2020

APA Citation

Kim, A., Lu, Y., Okuno, S., Reinke, D., Maertens, O., Perentesis, J., Basu, M., Wolters, P., De Raedt, T., Chawla, S., Chugh, R., Van Tine, B., O'Sullivan, G., Chen, A., Cichowski, K., & Widemann, B. (2020). Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).. Sarcoma, 2020 (). http://dx.doi.org/10.1155/2020/5784876

Peer Reviewed

1

Open Access

1